Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HSVTK GENE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 19 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Xie, XM; Zhao, XQ; Liu, YF; Young, CYF; Tindall, DJ; Slawin, KM; Spencer, DM
      Robust prostate-specific expression for targeted gene therapy based on thehuman kallikrein 2 promoter

      HUMAN GENE THERAPY
    2. Tanaka, M; Fraizer, GC; De la Cerda, J; Cristiano, RJ; Liebert, M; Grossman, HB
      Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery

      GENE THERAPY
    3. Namba, H; Iwadate, Y; Kawamura, K; Sakiyama, S; Tagawa, M
      Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells

      CANCER GENE THERAPY
    4. Zheng, XY; Johansson, M; Karlsson, A
      Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea

      MOLECULAR PHARMACOLOGY
    5. Dalgleish, AG; Perry, MJA; Eaton, JD; Hrouda, D; Todryk, SM; Kirby, RS
      The immunotherapy of prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    6. Stribbling, SM; Friedlos, F; Martin, J; Davies, L; Spooner, RA; Marais, R; Springer, CJ
      Regressions of established breast carcinoma xenografts by carboxypeptidaseG2 suicide gene therapy and the prodrug CMDA are due to a bystander effect

      HUMAN GENE THERAPY
    7. Dupont, F; Avalosse, B; Karim, A; Mine, N; Bosseler, M; Maron, A; Van den Broeke, A; Ghanem, GE; Burny, A; Zeicher, M
      Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector

      GENE THERAPY
    8. Todo, T; Rabkin, SD; Martuza, RL
      Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors

      CANCER GENE THERAPY
    9. Grignet-Debrus, C; Cool, V; Baudson, N; Velu, T; Calberg-Bacq, CM
      The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella tester and Herpes simplex viral thymidine kinases in suicide gene therapy

      CANCER GENE THERAPY
    10. Lechanteur, C; Delvenne, P; Princen, F; Lopez, M; Fillet, G; Gielen, J; Merville, MP; Bours, V
      Combined suicide and cytokine gene therapy for peritoneal carcinomatosis

      GUT
    11. Dilber, MS; Phelan, A; Aints, A; Mohamed, AJ; Elliott, G; Smith, CE; O'Hare, P
      Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22

      GENE THERAPY
    12. Hlavaty, J; Hlubinova, K; Bies, J; Altaner, C
      Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy

      NEOPLASMA
    13. Touraine, RL; Ishii-Morita, H; Ramsey, WJ; Blaese, RM
      The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication

      GENE THERAPY
    14. STERMAN DH; KAISER LR; ALBELDA SM
      GENE-THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA

      Hematology/oncology clinics of North America
    15. Thomas, SM; Naresh, KN; Wagle, AS; Mulherkar, R
      Preclinical studies on suicide gene therapy for head/neck cancer: A novel method for evaluation of treatment efficacy

      ANTICANCER RESEARCH
    16. BRIDGEWATER JA; KNOX RJ; PITTS JD; COLLINS MK; SPRINGER CJ
      THE BYSTANDER EFFECT OF THE NITROREDUCTASE CB-1954 ENZYME PRODRUG SYSTEM IS DUE TO A CELL-PERMEABLE METABOLITE

      Human gene therapy
    17. LECHANTEUR C; PRINCEN F; LOBUE S; DETROZ B; GIELEN J; BOURS V; MERVILLE MP
      HSV-1 THYMIDINE KINASE GENE-THERAPY FOR COLORECTAL ADENOCARCINOMA-DERIVED PERITONEAL CARCINOMATOSIS

      Gene therapy
    18. ALBELDA SM
      GENE-THERAPY FOR LUNG-CANCER AND MESOTHELIOMA

      Chest
    19. YAROVOI SV; MOUAWAD R; COLBEREGARAPIN F; SOUBRANE C; KHAYAT D; RIXE O
      IN-VITRO SENSITIZATION, OF THE B16 MURINE MELANOMA-CELLS TO GANCICLOVIR BY DIFFERENT RNA AND PLASMID DNA CONSTRUCTIONS ENCODING HSVTK

      Gene therapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 06:20:14